LivaNova (LIVN) Revenue Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 11.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20% |
| Dec 31, 2025 | 9.50% |
| Sep 30, 2025 | 12.30% |
| Jun 30, 2025 | 11.52% |
| Mar 31, 2025 | 9.68% |
| Dec 31, 2024 | 6.02% |
| Sep 30, 2024 | 7.90% |
| Jun 30, 2024 | 6.40% |
| Mar 31, 2024 | 6.00% |
| Dec 31, 2023 | 4.79% |
| Sep 30, 2023 | 6.02% |
| Jun 30, 2023 | 17.27% |
| Mar 31, 2023 | 2.81% |
| Dec 31, 2022 | -1.50% |
| Sep 30, 2022 | -2.03% |
| Jun 30, 2022 | -2.85% |
| Mar 31, 2022 | -1.43% |
| Dec 31, 2021 | -3.12% |
| Sep 30, 2021 | -2.37% |
| Jun 30, 2021 | -2.74% |
| Mar 31, 2021 | -0.37% |
| Dec 31, 2020 | -1.07% |
| Sep 30, 2020 | -1.50% |
| Jun 30, 2020 | -10.70% |
| Mar 31, 2020 | 2.24% |
| Dec 31, 2019 | 4.83% |
| Sep 30, 2019 | 4.04% |
| Jun 30, 2019 | 3.29% |
| Mar 31, 2019 | 3.65% |